ATE421994T1 - Genexpressionsmethode - Google Patents

Genexpressionsmethode

Info

Publication number
ATE421994T1
ATE421994T1 AT04806256T AT04806256T ATE421994T1 AT E421994 T1 ATE421994 T1 AT E421994T1 AT 04806256 T AT04806256 T AT 04806256T AT 04806256 T AT04806256 T AT 04806256T AT E421994 T1 ATE421994 T1 AT E421994T1
Authority
AT
Austria
Prior art keywords
protein
gene encoding
host cell
heterologous protein
gene expression
Prior art date
Application number
AT04806256T
Other languages
English (en)
Inventor
Darrell Sleep
Gillian Shuttleworth
Christopher John Arthur Finnis
Original Assignee
Novozymes Biopharma Dk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes Biopharma Dk As filed Critical Novozymes Biopharma Dk As
Application granted granted Critical
Publication of ATE421994T1 publication Critical patent/ATE421994T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT04806256T 2003-12-23 2004-12-23 Genexpressionsmethode ATE421994T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0329681.1A GB0329681D0 (en) 2003-12-23 2003-12-23 Gene expression technique

Publications (1)

Publication Number Publication Date
ATE421994T1 true ATE421994T1 (de) 2009-02-15

Family

ID=30776264

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04806256T ATE421994T1 (de) 2003-12-23 2004-12-23 Genexpressionsmethode

Country Status (15)

Country Link
US (3) US20070275889A1 (de)
EP (2) EP2048236B1 (de)
JP (1) JP5052899B2 (de)
KR (1) KR101262682B1 (de)
CN (2) CN101818121A (de)
AT (1) ATE421994T1 (de)
AU (2) AU2004303601C1 (de)
CA (1) CA2551503A1 (de)
DE (1) DE602004019304D1 (de)
DK (1) DK2048236T3 (de)
ES (1) ES2321948T3 (de)
GB (2) GB0329681D0 (de)
SG (2) SG149003A1 (de)
WO (1) WO2005061718A1 (de)
ZA (1) ZA200605588B (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003066824A2 (en) * 2002-02-07 2003-08-14 Aventis Behring Gmbh Albumin-fused kunitz domain peptides
US9057061B2 (en) 2003-12-23 2015-06-16 Novozymes Biopharma Dk A/S Gene expression technique
GB0329722D0 (en) * 2003-12-23 2004-01-28 Delta Biotechnology Ltd Modified plasmid and use thereof
WO2006067511A1 (en) 2004-12-23 2006-06-29 Novozymes Delta Limited Gene expression technique
GB0512707D0 (en) * 2005-06-22 2005-07-27 Delta Biotechnology Ltd Gene expression technique
CN101511868B (zh) 2006-07-24 2013-03-06 比奥雷克西斯制药公司 毒蜥外泌肽融合蛋白
GB0711424D0 (en) * 2007-06-13 2007-07-25 Novozymes Delta Ltd Recombinant transferrin mutants
WO2009019314A1 (en) 2007-08-08 2009-02-12 Novozymes A/S Transferrin variants and conjugates
ES2537806T5 (es) 2007-10-31 2018-10-09 Daiichi Sankyo Company, Limited Método para la secreción y producción de alto nivel de proteína
TR201813067T4 (tr) 2008-09-15 2018-09-21 Uniqure Biopharma B V Faktör IX polipeptit mutantı, bunun kullanımları ve bunu üretmeye yönelik bir yöntem.
WO2010034708A1 (en) * 2008-09-23 2010-04-01 Unilever Plc A polynucleotide expression cassette
KR101722961B1 (ko) 2009-02-11 2017-04-04 알부메딕스 에이/에스 알부민 변이체 및 접합체
DK2427486T3 (en) 2009-05-07 2015-05-26 Novozymes Biopharma Dk As A process for purifying albumin
EP2258854A1 (de) 2009-05-20 2010-12-08 FH Campus Wien Eukaryotische Wirtszelle mit einem Ausdrucksverstärker
FI20095615A0 (fi) * 2009-06-02 2009-06-02 Oulun Yliopisto Menetelmä luonnollisesti laskostuneiden proteiinien tuottamiseksi prokaryootti-isännässä
EP2493921B1 (de) 2009-10-30 2018-09-26 Albumedix Ltd Albuminvarianten
CN103641896B (zh) * 2009-11-19 2015-08-05 浙江大学 明胶样单元的用途
GB201000587D0 (en) * 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
EP2556087A1 (de) 2010-04-09 2013-02-13 Novozymes Biopharma DK A/S Albuminderivate und varianten
CN102533839B (zh) * 2010-12-21 2017-06-20 上海开阳生物科技有限公司 融合表达含有二硫键蛋白质的方法
EP2565262A1 (de) * 2011-08-31 2013-03-06 VTU Holding GmbH Protein-Expression
EP2780364A2 (de) 2011-11-18 2014-09-24 Eleven Biotherapeutics, Inc. Proteine mit verbesserter halbwertzeit und anderen eigenschaften
DK2825556T3 (en) 2012-03-16 2018-04-16 Albumedix As albumin Variants
MX2015005363A (es) 2012-11-08 2015-11-06 Novozymes Biopharma Dk As Variantes de albumina.
CN102994541B (zh) * 2012-12-19 2015-04-15 江南大学 一种共表达upr关键基因和下游靶基因增强葡萄糖氧化酶分泌的方法
JP5985040B2 (ja) 2013-02-28 2016-09-06 株式会社日立ハイテクノロジーズ データ解析装置、及びその方法
CN103436516B (zh) * 2013-08-23 2015-04-22 华南理工大学 利用大肠杆菌原核表达系统生产的小麦蛋白质二硫键异构酶及方法和应用
AU2015248807B2 (en) 2014-04-17 2021-07-22 Boehringer Ingelheim Rcv Gmbh & Co Kg Recombinant host cell for expressing proteins of interest
CN106661541B (zh) 2014-04-17 2021-09-03 贝林格尔·英格海姆Rcv两合公司 被工程化为过表达辅助蛋白的重组宿主细胞
JP7007261B2 (ja) 2015-08-20 2022-01-24 アルブミディクス リミティド アルブミン変異体及びコンジュゲート
EP3394243A1 (de) 2015-12-22 2018-10-31 Albumedix Ltd. Verbesserte proteinexpressionsstämme
JP7146637B2 (ja) 2015-12-22 2022-10-04 アルブミディクス リミティド 改善されたタンパク質発現株
WO2017190671A1 (zh) * 2016-05-04 2017-11-09 北京普罗吉生物科技发展有限公司 高效表达重组人血清白蛋白工程菌的构建
JP7227159B2 (ja) 2017-01-16 2023-02-21 ナンシャ・バイオロジックス・(ホンコン)・リミテッド 酵母における組換えil-11の生産のためのシステムおよび方法
CN106834322B (zh) * 2017-03-14 2020-09-04 中国科学院南海海洋研究所 抗毒素so_1445或其编码基因在提高质粒在宿主细胞中的稳定性中的应用
US11130979B2 (en) 2017-06-20 2021-09-28 Albumedix Ltd Protein expression strains
WO2019006348A1 (en) * 2017-06-30 2019-01-03 Western University Of Health Sciences IX-TRANSFERRIN FACTOR FUSION PROTEINS
DK3775222T5 (da) * 2018-03-26 2024-08-19 Novozymes As Chaperoneproteiner fra svampe
CN112391402B (zh) * 2020-11-17 2023-03-28 华中科技大学 一种提高解脂耶氏酵母中目的蛋白表达水平的方法
US20240150807A1 (en) * 2021-03-10 2024-05-09 Sumitomo Pharma Co., Ltd. Method for Producing Cysteine Knot Protein
CN114410496B (zh) * 2022-02-16 2023-10-03 江南大学 一种提高毕赤酵母外源蛋白产量的方法
KR20240094203A (ko) * 2022-12-15 2024-06-25 씨제이제일제당 (주) 트리코더마 속 균주 유래 pdi를 이용하여 재조합 단백질을 생산하는 방법
CN117903295B (zh) * 2024-03-19 2024-05-31 北京国科星联科技有限公司 一种用于分泌表达乳铁蛋白的马克斯克鲁维酵母及其构建方法与应用
CN118460394B (zh) * 2024-07-12 2024-09-24 通化安睿特生物制药股份有限公司 一种用于制备转铁蛋白的工程菌及其应用
CN118895293B (zh) * 2024-10-08 2025-01-28 通化安睿特生物制药股份有限公司 一种产人白蛋白的重组工程菌及其构建方法和应用

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019919D0 (en) 1990-09-12 1990-10-24 Delta Biotechnology Ltd Purification of proteins
US4302386A (en) * 1978-08-25 1981-11-24 The Ohio State University Antigenic modification of polypeptides
NZ199722A (en) 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
IL66614A (en) 1981-08-28 1985-09-29 Genentech Inc Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it
CA1205935A (en) 1981-09-14 1986-06-10 Union Carbide Corporation Process for producing a polymer water-in-oil emulsion
GB8615701D0 (en) * 1986-06-27 1986-08-06 Delta Biotechnology Ltd Stable gene integration vector
GB8620926D0 (en) 1986-08-29 1986-10-08 Delta Biotechnology Ltd Yeast promoter
JP2873012B2 (ja) * 1987-04-09 1999-03-24 デルタ バイオテクノロジー リミテッド 酵母ベクター
IL86455A0 (en) 1987-06-01 1988-11-15 Takeda Chemical Industries Ltd Polypeptide and production thereof
IL88326A (en) 1987-11-18 1993-03-15 Gist Brocades Nv Purification of serum albumin
EP0387319B1 (de) 1988-07-23 1996-03-06 Delta Biotechnology Limited Sekretorische leader-sequenzen
FR2649991B2 (fr) * 1988-08-05 1994-03-04 Rhone Poulenc Sante Utilisation de derives stables du plasmide pkd1 pour l'expression et la secretion de proteines heterologues dans les levures du genre kluyveromyces
US5759802A (en) 1988-10-26 1998-06-02 Tonen Corporation Production of human serum alubumin A
GB8909916D0 (en) 1989-04-29 1989-06-14 Delta Biotechnology Ltd Polypeptides
US5571691A (en) * 1989-05-05 1996-11-05 Baylor College Of Medicine Production of recombinant lactoferrin and lactoferrin polypeptides using CDNA sequences in various organisms
GB8927480D0 (en) 1989-12-05 1990-02-07 Delta Biotechnology Ltd Mutant fungal strain detection and new promoter
JP3230091B2 (ja) 1990-06-25 2001-11-19 ウェルファイド株式会社 ヒト血清アルブミンの着色抑制方法
KR930701625A (ko) * 1990-07-13 1993-06-12 리처드 에프. 셀든 라이브러리 스크리닝 방법
EP0509841A3 (en) 1991-04-18 1993-08-18 Tonen Corporation Co-expression system of protein disulfide isomerase gene and useful polypeptide gene and process for producing the polypeptide using its system
US6291205B1 (en) 1992-06-12 2001-09-18 Merck & Co., Inc. Method of increasing production of disulfide bonded recombinant proteins by saccharomyces cerevisiae
AU4571993A (en) * 1992-07-29 1994-03-03 Unilever Plc Process for producing anti-freeze peptides
DE4244915C2 (de) 1992-08-14 1998-12-03 Widmar Prof Dr Tanner DNA-Moleküle codierend Proteine, die an der O-Glykosylierung von Proteinen beteiligt sind
US5728553A (en) 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
ATE195347T1 (de) * 1992-10-02 2000-08-15 Res Corp Technologies Inc Methoden der erhöhung der sekretion von überexpremierten proteinen
GB9404270D0 (en) 1994-03-05 1994-04-20 Delta Biotechnology Ltd Yeast strains and modified albumins
GB9411356D0 (en) * 1994-06-07 1994-07-27 Delta Biotechnology Ltd Yeast strains
JP3945866B2 (ja) * 1996-09-04 2007-07-18 サントリー株式会社 メタノール酵母由来のプロテインジスルフィドイソメラーゼ遺伝子
IL134446A0 (en) 1997-09-05 2001-04-30 Pentapharm Ag Expression vector for improved production of polypeptides in yeast
CN1111602C (zh) * 1998-05-15 2003-06-18 中国科学院上海生物化学研究所 一种使用分子伴侣促进蛋白质分泌的方法
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
EP1077263A1 (de) * 1999-07-29 2001-02-21 F.Hoffmann-La Roche Ag Verfahren zur Herstellung von natürlich gefalteten und sekretierten Proteinen durch Co-Sekretion von Chaperonen
EP2213743A1 (de) 2000-04-12 2010-08-04 Human Genome Sciences, Inc. Albuminfusionsproteine
US6358733B1 (en) * 2000-05-19 2002-03-19 Apolife, Inc. Expression of heterologous multi-domain proteins in yeast
DE10121235A1 (de) * 2001-04-30 2002-10-31 Roche Diagnostics Gmbh Verfahren zur Expression von Proteinen in in vitro Translations-Systemen unter Ko-Expression von Faltungshelferproteinen
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
US20030226155A1 (en) 2001-08-30 2003-12-04 Biorexis Pharmaceutical Corporation Modified transferrin-antibody fusion proteins
DE10145694A1 (de) * 2001-09-17 2003-04-03 Roche Diagnostics Gmbh Verfahren zur Erhöhung der Löslichkeit, der Expressionsrate und der Aktivität von Proteinen während der rekombinanten Herstellung
CA2471178A1 (en) * 2002-01-07 2003-07-17 European Molecular Biology Laboratory Recombinant protein expression
WO2003066824A2 (en) 2002-02-07 2003-08-14 Aventis Behring Gmbh Albumin-fused kunitz domain peptides
CA2496002A1 (en) 2002-08-07 2004-02-19 Delta Biotechnology Ltd. Albumin-fused ciliary neurotrophic factor
US6939676B2 (en) * 2002-12-30 2005-09-06 The United States Of America As Represented By The Secretary Of Argriculture Selection procedure for identifying transgenic cells, embryos, and plants without the use of antibiotics
US7244616B2 (en) * 2003-06-27 2007-07-17 Bayer Pharmaceuticals Corporation Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells
US7226781B1 (en) * 2003-07-24 2007-06-05 Belyaev Alexander S Chaperone expression genomes
BRPI0513826A2 (pt) * 2004-07-26 2010-06-22 Dow Global Technologies Inc processo para expressão de proteìna melhorada através de engenharia de cepa

Also Published As

Publication number Publication date
US20120231503A1 (en) 2012-09-13
AU2004303601B2 (en) 2008-03-06
EP2048236A1 (de) 2009-04-15
US20180105818A1 (en) 2018-04-19
KR20070005568A (ko) 2007-01-10
CN101818121A (zh) 2010-09-01
SG182155A1 (en) 2012-07-30
DE602004019304D1 (de) 2009-03-19
DK2048236T3 (da) 2013-05-21
CN1922325B (zh) 2010-06-09
US20070275889A1 (en) 2007-11-29
CA2551503A1 (en) 2005-07-07
WO2005061718A1 (en) 2005-07-07
KR101262682B1 (ko) 2013-05-15
JP5052899B2 (ja) 2012-10-17
GB0614614D0 (en) 2006-08-30
AU2004303601C1 (en) 2009-01-08
JP2007515962A (ja) 2007-06-21
EP1709181A1 (de) 2006-10-11
HK1099938A1 (en) 2007-08-31
EP1709181B1 (de) 2009-01-28
GB0329681D0 (en) 2004-01-28
EP2048236B1 (de) 2013-03-20
AU2008202538A1 (en) 2008-06-26
ES2321948T3 (es) 2009-06-15
SG149003A1 (en) 2009-01-29
CN1922325A (zh) 2007-02-28
ZA200605588B (en) 2009-02-25
GB2424889A (en) 2006-10-11
AU2004303601A1 (en) 2005-07-07

Similar Documents

Publication Publication Date Title
ATE421994T1 (de) Genexpressionsmethode
PE20090731A1 (es) Metodos de produccion de proteinas basados en medios de cultivos celulares que comprenden compuestos anti-senescencia
ATE405586T1 (de) Verfahren zur regulierung der immunfunktion in primaten unter verwendung des foxp3-proteins
WO2003012058A3 (en) Media and methods for cultivation of microorganisms
ATE374828T1 (de) Expressionsvektor zur antibiotikafreien expression
SG162834A1 (en) Refolding of recombinant proteins
EP2330200A3 (de) Genexpressionstechnik
DK0956338T3 (da) Værtsceller og fremgangsmåder til produktion af proteiner
DE60213803D1 (en) Happier mapping
WO2006127809A3 (en) Methods for expansion and analysis of cultured hematopoietic stem cells
ATE353953T1 (de) Wirtszelle, die reduzierte mengen einer metalloprotease exprimiert und methoden zur verwendung dieser wirtszelle zur proteinproduktion
DE502007005530D1 (de) Mikroorganismenstamm zur Produktion von rekombinanten Proteinen
AU8491401A (en) Phage-dependent superproduction of biologically active protein and peptides
ATE555194T1 (de) Methode zur herstellung von proliferierenden und differenzierenden zelllinien
ATE454444T1 (de) Verfahren zur herstellung rekombinanter proteine
ATE387497T1 (de) Samenspezifische 7s-alpha-promoter zur expression von genen in pflanzen
EP1847611A3 (de) Rhamnose-induzierbares Expressionssystem
DK1639119T3 (da) Fremgangsmåde til mikrobiologisk isomerisering af alpha-hydroxycarboxylsyrer
ATE451457T1 (de) Verfahren zur dipeptidherstellung
DE60040077D1 (de) Vermehrungsproteine von pflanzen
DE60040789D1 (de) Verfahren zur aufreinigung heterologer proteine
ATE486124T1 (de) Keratinozyten-kulturverfahren und verwendung davon
DE10393455D2 (de) DNA-Expressionskonstrukt zur multiplen Genexpression
MX2023015460A (es) Celula huesped de bacillus mejorada con proteina rema/remb alterada.
WO2002064811A3 (fr) Procede pour produire des proteines recombinantes, marquees par au moins un isotope

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1709181

Country of ref document: EP